Bio

Clinical Focus


  • Anesthesia

Academic Appointments


Professional Education


  • Internship:Baylor College of Medicine (2005) TX
  • Board Certification: Anesthesia, American Board of Anesthesiology (2010)
  • Residency:Stanford University Medical Center - Anesthesia (2008) CA
  • Medical Education:Baylor College of Medicine (2004) TX

Research & Scholarship

Clinical Trials


  • Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery. Not Recruiting

    The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

    Stanford is currently not accepting patients for this trial.

    View full details

  • In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography. Not Recruiting

    Oxytocin is normally administered following delivery in pregnant patients to reduce postpartum bleeding by increasing uterine tone. It is unclear whether the use of intravenous oxytocin alters coagulation in pregnant patients. The purpose of the in-vitro study is to assess the coagulation changes of oxytocin in blood samples from pregnant patients using thromboelastrography (TEG). TEG is a point-of-care device which measures the viscoelastic properties of clot formation, and can provide rapid and detailed information about coagulation changes. We aim to collect blood samples from pregnant patients to assess the in-vitro effects of synthetic oxytocin on coagulation using TEG.

    Stanford is currently not accepting patients for this trial.

    View full details

  • Effects of Epidural Lidocaine on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® After Cesarean Delivery Not Recruiting

    The purpose of this study is to evaluate the levels of morphine in a patients blood when morphine is given into the epidural space in the form of DepoDur® either alone or following a dose of lidocaine also given in the epidural space. Specifically, we are looking at pregnant women undergoing cesarean delivery who will be receiving these medications. A secondary objective is to evaluate the how well DepoDur® works for pain control, as well as its safety, when it is given either alone or following a dose of epidural lidocaine.

    Stanford is currently not accepting patients for this trial. For more information, please contact Brendan Carvalho, (650) 861 - 8607.

    View full details

Stanford Medicine Resources: